Mind Medicine (MNMD) Appoints Robert Barrow as CEO and Director

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. CRWV
2. NVDA
3. SPY
4. BAC
5. BLK
6. CAT
7. AA
8. RKLB
9. RXRX
10. NOW

Go back to Mind Medicine (MNMD) Appoints Robert Barrow as CEO and Director

MindMed Appoints Robert Barrow as Chief Executive Officer and Director

December 14, 2021 7:30 AM EST

-Mr. Barrow previously served as interim Chief Executive Officer and Chief Development Officer of MindMed

-Carol Vallone appointed as Chair of the Board of Directors, Andreas Krebs appointed as Vice Chair and Perry Dellelce transitions from his role as Chairman-

NEW YORK, Dec. 14, 2021 /PRNewswire/ -- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the "Company"), a leading biotech company developing psychedelic-inspired therapies, today announced that Robert Barrow was appointed as Chief... More